Arbovirus Infections - 106 Studies Found
Completed |
: Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study : Japanese Encephalitis : 2010-10-06 :
|
Completed |
: This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population : Japanese Encephalitis : 2010-07-07 : Biological: IXIARO® IXIARO®, 0.5 ml (6 µg), intramuscular (i.m.) injection, two vaccinati |
Completed |
: Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea : Japanese Encephalitis : 2010-06-24 : Biological: JE vaccine 3 times, IM |
Completed |
: Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine : Japanese Encephalitis : 2009-09-21 :
|
Completed |
: A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults :
: 2009-09-21 :
|
Completed |
: Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling : Japanese Encephalitis : 2008-10-20 : Biological: IC51 6 mcg im. at day 0 and day 28 Other |
Completed |
: Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers :
: 2008-05-30 : |
Completed |
: Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440 : Japanese Encephalitis : 2008-01-04 :
|
Completed |
: Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age : Japanese Encephalitis : 2007-02-27 :
|
Completed |
: A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX : Japanese Encephalitis : 2006-04-28 :
|